Search
Research
Rio Tinto Child Health Partnership Final ReportIn 2002, the Founding Director of The Kids for Child Health Research, Professor Fiona Stanley, approached Rio Tinto Ltd about the possibility...
Research
Investigating genotype-phenotype relationships in Rett syndrome using an international data setThis study uses data from a large international database, InterRett, to examine genotype-phenotype relationships and compares these with previous findings in...
Research
Late language emergence at 24 months: an epidemiological study of prevalence, predictors, and covariatesThe primary objectives of this study were to determine the prevalence of late language emergence (LLE) and to investigate the predictive status of maternal...
Research
Diverging trends for lower respiratory infections in non-Aboriginal and Aboriginal childrenTo investigate temporal trends in admission rates for acute lower respiratory infections (ALRI) in a total population birth cohort of non-Aboriginal and...
Research
Vaccinating young adults against HPV: the importance of understanding health decision-making and behaviourVaccination of young teenage females against human papillomavirus (HPV) with a newly licenced quadrivalent vaccine designed to prevent cervical cancer and...
At The Kids Research Institute Australia, we pride ourselves on conducting research to the highest standards possible. See our Research Governance process in more detail.
We believe the way we reward research excellence is better than anywhere in the nation. Find out about the ways The Kids Research Institute Australia rewards our researchers.
Research
Cystic Fibrosis Early Surveillance ProgramResearchers are able to track the progress of lung disease through a comprehensive longitudinal set of biological samples, images and data archives.
Our team aims to optimise lung health early in life to ensure the best possible health outcomes later in life.
Research
National Hybrid Closed-Loop Outpatient TrialThe national Hybrid Closed-Loop Outpatient Trial will test the use of an automated insulin delivery system to see if it is better at optimising blood glucose levels than standard therapy.